Furthermore, EI24 silencing enhanced the proliferation of ESCC cells and the growth of implanted tumors and repressed cell apoptosis but enhanced chemotherapy resistance to 5-FU, CDDP, ADR, and vincristine (VCR), whereas EI24 overexpression exhibited opposite effects. The gene discussed is EI24; the disease is esophageal squamous cell carcinoma.